Publicaciones en colaboración con investigadores/as de Hospital Clínico Universitario Lozano Blesa (69)

2026

  1. Antiretroviral treatment in people living with HIV with late diagnosis initiating ART with DTG/3TC or BIC/TAF/FTC: A real-world cohort analysis

    HIV Medicine, Vol. 27, Núm. 1, pp. 96-105

  2. CEBPA-bZIP Mutations in AML Patients Treated With Non-Intensive Therapy: A Study by the Spanish PETHEMA Registry

    Hematological Oncology, Vol. 44, Núm. 1

  3. Clinical outcomes of long-acting cabotegravir and rilpivirine in people with HIV aged 60 and older: Real-world data from the Spanish RELATIVITY cohort

    HIV Medicine, Vol. 27, Núm. 1, pp. 58-73

  4. Comparable Inflammatory and Metabolic Outcomes after Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults with HIV (INSTINCT/GESIDA10918 Study)

    Clinical Infectious Diseases, Vol. 82, Núm. 2, pp. e262-e274

  5. Determinants of long-acting cabotegravir plus rilpivirine discontinuation in real-world HIV care: insights from the RELATIVITY cohort

    AIDS, Vol. Publish Ahead of Print

  6. Effectiveness and Persistence of Long-Acting Injectable Cabotegravir and Rilpivirine in Migrant Individuals Living With HIV in Spain: Substudy of the RELATIVITY Cohort

    Journal of the International AIDS Society, Vol. 29, Núm. 4

  7. Finerenone in heart failure with ejection fraction ≥40%: state of the art and future perspectives

    Revista Clinica Espanola

  8. Genotyping not required for sustained effectiveness of long-acting cabotegravir plus rilpivirine: evidence from the RELATIVITY cohort

    AIDS (London, England), Vol. 40, Núm. 4, pp. 414-427

  9. How can we optimize the diagnostic and therapeutic approach of urinary tract infection? Expert opinion-based recommendations

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 44, Núm. 1

  10. Long-acting cabotegravir and rilpivirine in people with HIV and obesity: Real-world outcomes from the RELATIVITY cohort

    HIV Medicine, Vol. 27, Núm. 5, pp. 690-709

  11. Predicting early clinical recovery in first-episode psychosis: development and external validation of a clinically interpretable multivariable model

    British Journal of Psychiatry

  12. Prognostic value of the FIB-4 and FIB-5 indices in patients hospitalised for acute heart failure. Analysis of the RICA-2 registry

    Revista Clinica Espanola

  13. Quizartinib for Newly Diagnosed FLT3-Internal Tandem Duplication–Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI Study

    Journal of Clinical Oncology

  14. Recurrence factors in familial papillary thyroid carcinoma

    Minerva endocrinology, Vol. 51, Núm. 1, pp. 4-16

  15. Therapeutic Apheresis Registry of the Spanish Society of Nephrology. Analysis of activity over the last five years

    Nefrologia, Vol. 46, Núm. 2

  16. Trends in 90-Day Mortality, Recurrent Venous Thrombosis, and Bleeding in Patients With Pulmonary Embolism

    Journal of the American College of Cardiology, Vol. 87, Núm. 13, pp. 1539-1542

2025

  1. A prospective assessment of the efficacy and durability of long-acting cabotegravir and rilpivirine in individuals with HIV in Spain (RELATIVITY study)

    Journal of Antimicrobial Chemotherapy, Vol. 80, Núm. 12, pp. 3438-3451

  2. Are children and adolescents living with HIV in Europe and South Africa at higher risk of SARS-CoV-2 and poor COVID-19 outcomes?

    Epidemiology and Infection, Vol. 153

  3. Co-infections during SARS-CoV-2 infection in hematologic patients and cell therapy recipients in the omicron era: a Spanish hematopoietic stem cell transplantation and cell therapy group study

    BMC infectious diseases, Vol. 25, Núm. 1, pp. 944

  4. Comparative Efficacy and Immunogenicity of Infliximab and Adalimumab in Crohn’s Disease: A Prospective Cohort Study

    Medicina (Lithuania), Vol. 61, Núm. 12